Page 11 - Vitamin D and Cancer
P. 11
x Contributors
Edward Giovannucci M.D., ScD
Department of Nutrition, 2–371, Harvard School of Public Health,
665 Huntington Avenue, Boston, MA 02115, USA
and
Department of Epidemiology, Harvard School of Public Health,
Boston, MA 02115, USA
and
Channing Laboratory, Department of Medicine,
Brigham and Women’s Hospital and Harvard Medical School,
181 Longwood Avenue, Boston, MA 02115, USA
Elzbieta Gocek
Faculty of Biotechnology, University of Wroclaw, Tamka 2, 50–137 Wroclaw,
Poland
Bruce W. Hollis Ph.D.
Department of Pediatrics, Darby Children’s Research Institute,
Medical University of South Carolina, 173 Ashley Ave., Room 313,
Charleston, SC 29425, USA
Candace S. Johnson Ph.D.
Deputy Director, Chair, Pharmacology & Therapeutics, Roswell Park Cancer Institute,
Elm & Carlton Streets, Buffalo, NY 14263, USA
H. Phillip Koeffler M.D.
Director, Hematology/Oncology Division, Cedar-Sinai Medical Center,
8700 Beverly Blvd, Los Angeles, CA 90048, USA
Aruna V. Krishnan
Stanford University School of Medicine, 300 Pasteur Drive, Room S-025,
Stanford, CA 94305–5103, USA
Yingyu Ma M.D., Ph.D.
Pharmacology & Therapeutics, Roswell Park Cancer Institute,
Elm & Carlton Streets, Buffalo, NY 14263, USA
Josephia Muindi M.D., Ph.D.
Associate Professor of Oncology, Roswell Park Cancer Institute,
Elm and Carlton Streets, Buffalo, NY 14263, USA
Carmen J. Narvaez Ph.D.
GenNYsis Center for Excellence in Cancer Genomics,
122H Cancer Research Center, 1 Discovery Drive, Rensselaer, NY 12144, USA
Ryoko Okamoto Ph.D.
Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA
School of Medicine, 8700 Beverly Blvd, Los Angeles, CA 90048, USA